Simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma using high-performance liquid chromatography.
A simple, specific and sensitive high-performance liquid chromatographic method has been developed for the simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma. Plasma, spiked with internal standard, was vortex-mixed for 1 min with a mixture of dichloromethane-diethyl ether (80:20, v/v). The evaporated extract was dissolved in 0.02 M NaOH. Drugs were resolved at room temperature on a 5 microns Zorbax SAX column (250 x 4.6 mm I.D.) equipped with a 20 x 4.6 mm anion-exchange Vydac AXGU (10 microns particle size) precolumn. The mobile phase consisted of acetonitrile and phosphate buffer (pH 7.0), delivered at a flow-rate of 1.2 ml/min. Detection was made at 280 nm. 2-[4-(2'-Furoyl)phenyl]propionic acid was used as internal standard. The calibration curve was linear from 0.2 to 10 micrograms/ml for rufloxacin, from 0.5 to 30 micrograms/ml for fenbufen and from 0.2 to 10 micrograms/ml for felbinac, respectively. The detection limit was 0.1 microgram/ml for rufloxacin, 0.3 microgram/ml for fenbufen and 0.1 microgram/ml for felbinac, respectively.
Carlucci
G
G
Dipartimento di Chimica, Ingegneria Chimica e Materiali, Università dell'Aquila, Coppito, Italy.
Mazzeo
P
P
Palumbo
G
G
D000890:Anti-Infective Agents / Q000097:blood*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000097:blood*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D024841:Fluoroquinolones; D006801:Humans; D010648:Phenylacetates / Q000097:blood*; D010654:Phenylbutyrates / Q000097:blood*; D015363:Quinolones / Q000097:blood*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D024841:Fluoroquinolones; D010648:Phenylacetates; D010654:Phenylbutyrates; D015363:Quinolones; C012776:biphenylylacetic acid; C010725:fenbufen; C060328:rufloxacin